COMMUNIQUÉS West-GlobeNewswire

Corporate Update

30/04/2025 - 15:17

Boston, MA, April 30, 2025 (GLOBE NEWSWIRE) -- Vystar ® Corporation (OTCQB: VYST) Vystar received notice of final approval of its Form 15C-211 application. In addition, today the Company moved from the Pink Sheets to [...]

BioSyent to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference

30/04/2025 - 15:25

MISSISSAUGA, Ontario, April 30, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2025 Bloom Burton & Co. Healthcare Investor [...]

X-Chem Expands Strategic Collaboration With Orion Pharma to Accelerate Orion’s Early Drug Discovery From Hit to Candidate

30/04/2025 - 16:01

WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global leader in DNA-encoded library (DEL) technology and data-driven drug discovery, has announced an expanded collaboration with Orion Pharma. The agreement [...]

Arialief Reviews (DOCTOR INVESTIGATION REVEALS) Natural, Science-Backed Relief for Chronic Pain & Inflammation

30/04/2025 - 16:48

Arialief offers innovative solutions for chronic pain and inflammation. Discover natural, non-addictive relief with our science-backed products. Improve your wellness journey today! FINDLAY, Ohio, April 30, 2025 (GLOBE [...]

NeuroSigma Announces New Clinical Trial of Monarch eTNS System for Treatment of ADHD in Children with Fetal Alcohol Syndrome at UCLA

30/04/2025 - 17:00

Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to alcohol during [...]

BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness

30/04/2025 - 17:25

KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) , a biotechnology company specializing in precision diagnostics and specialty chemical solutions, today announced that it [...]

Guidance updated: Impact from and mitigation to navigate the global trade environment

30/04/2025 - 17:31

Following the recent announcements by the U.S. administration regarding tariffs, GN now takes further actions to counter the negative direct and indirect effects from the increased tariff levels. With the actions, GN is [...]

ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions

30/04/2025 - 17:35

EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies to restore [...]

Mise à disposition du rapport financier annuel 2024

30/04/2025 - 17:45

Communiqué de presse Mise à disposition du rapport financier annuel 2024 Dijon, France le 30 avril 2025 (17h45 CET) -- CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée en phase [...]

Mise à disposition du rapport financier annuel 2024

30/04/2025 - 17:45

Communiqué de presse Mise à disposition du rapport financier annuel 2024 Dijon, France le 30 avril 2025 (17h45 CET) -- CROSSJECT (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée en phase [...]

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

30/04/2025 - 17:45

Leiden, the Netherlands, April 30, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that the Company’s 2025 Annual General Meeting of Shareholders (the “AGM”) [...]

Best Probiotics for Bloating and Gas 2025: Top Probiotic Gut Health Supplements from YourBiology

30/04/2025 - 17:47

GLASGOW, United Kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- YourBiology Gut+ is the best probiotic for bloating, gas, and constipation—powered by Lactobacillus, Bifidobacterium, prebiotics, enzymes, and Vitamin D3 to [...]

Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024

30/04/2025 - 18:00

Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2024 NANTES, France, 30 avril 2025, 18 heures - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), une société de [...]

IPSEN S.A - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale 2025

30/04/2025 - 18:00

Information réglementée Destiné uniquement aux médias internationaux et à la communauté d’investisseurs Informations concernant la tenue de l’Assemblée Générale Mixte du 21 mai 2025 d’Ipsen S.A. Modalités de mise à [...]

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

30/04/2025 - 13:30

Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study Biomarkers could be utilized to predict and provide better patient outcomes, including response rates [...]

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

30/04/2025 - 13:35

Highlights Reported positive topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial in Multiple System Atrophy (MSA) led by robust clinical efficacy Phase 2 data featured in an oral presentation at [...]

First AI-Driven Cognitive and Speech Therapy Platform for Spanish, English-Speaking Indian Communities

30/04/2025 - 13:43

Constant Therapy removes language barriers for non-native speakers with stroke, brain injury, or neurological conditions LEXINGTON, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Constant Therapy Health , a pioneer in [...]

Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders

30/04/2025 - 13:45

BETHESDA, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]

Best Testosterone Booster Supplement for Males Over 40: Why TestoPrime Leads for Muscle, Energy & Libido

30/04/2025 - 13:57

New York City, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Testosterone Support Matters After 40 As men age, maintaining strength, stamina, and masculinity becomes increasingly difficult — and one of the [...]